Lipitor may be a novel therapeutic option in patients with ulcerative colitis, according to study results published in Journal of the American Medical Informatics Association. “Long-term atorvastatin (Lipitor) use is associated...
Read MoreThe American Gastroenterological Association published a conceptual model and clinical practice update for the prevention, detection and management of colorectal dysplasia in patients with inflammatory bowel disease. “Not long...
Read MoreHealio Gastroenterology presents the following account of our latest inflammatory bowel disease coverage. These stories include topics regarding COVID-19 and IBD, therapeutic research, a preview of the ACG Annual Scientific...
Read MoreHigher visceral adipose tissue correlated with lower rates of inflammatory bowel disease remission among patients dosed with infliximab, vedolizumab or ustekinumab, according to Andres Yarur, MD, Medical College of Wisconsin. “A...
Read MoreThough there is no significant difference in COVID-19 infection rates among patients with inflammatory bowel disease compared with the general public, some IBD therapies correlated with increased infection severity. “The...
Read More
No abstract Full Text Link: https://libkey.io/34536074?utm_source=ibdwatch
Read MoreNo abstract Full Text Link: https://libkey.io/34534537?utm_source=ibdwatch
Read MoreNo abstract Full Text Link: https://libkey.io/34534289?utm_source=ibdwatch
Read MoreCONCLUSIONS: Together, our study demonstrates the power of IMC and its ability to both quantify immune cell types and characterize their spatial interactions within the inflammatory environment by a single analysis platform....
Read MoreCONCLUSIONS: The lower and less durable SARS-CoV-2 S-RBD IgG response to natural infection in IBD patients receiving biologics puts them at risk of reinfection. The robust response to immunization is likely protective. Full Text...
Read More